In the past week, AMED stock has gone up by 5.65%, with a monthly gain of 5.69% and a quarterly surge of 4.94%. The volatility ratio for the week is 1.80%, and the volatility levels for the last 30 days are 1.15% for Amedisys Inc. The simple moving average for the past 20 days is 5.28% for AMED’s stock, with a 4.12% simple moving average for the past 200 days.
Is It Worth Investing in Amedisys Inc. (NASDAQ: AMED) Right Now?
Company’s 36-month beta value is 0.79.Analysts have differing opinions on the stock, with 3 analysts rating it as a “buy,” 2 as “overweight,” 6 as “hold,” and 0 as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for AMED is 32.07M, and currently, short sellers hold a 7.35% ratio of that floaft. The average trading volume of AMED on July 04, 2024 was 300.84K shares.
AMED) stock’s latest price update
The stock of Amedisys Inc. (NASDAQ: AMED) has increased by 0.48 when compared to last closing price of 96.74.Despite this, the company has seen a gain of 5.65% in its stock price over the last five trading days. zacks.com reported 2024-05-29 that Whether you’re a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Analysts’ Opinion of AMED
Truist, on the other hand, stated in their research note that they expect to see AMED reach a price target of $97. The rating they have provided for AMED stocks is “Hold” according to the report published on June 07th, 2023.
Cantor Fitzgerald gave a rating of “Neutral” to AMED, setting the target price at $87 in the report published on April 21st of the previous year.
AMED Trading at 4.29% from the 50-Day Moving Average
After a stumble in the market that brought AMED to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -0.16% of loss for the given period.
Volatility was left at 1.15%, however, over the last 30 days, the volatility rate increased by 1.80%, as shares surge +5.47% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +6.64% upper at present.
During the last 5 trading sessions, AMED rose by +5.76%, which changed the moving average for the period of 200-days by +3.81% in comparison to the 20-day moving average, which settled at $92.58. In addition, Amedisys Inc. saw 2.25% in overturn over a single year, with a tendency to cut further gains.
Stock Fundamentals for AMED
Current profitability levels for the company are sitting at:
- 0.07 for the present operating margin
- 0.47 for the gross margin
The net margin for Amedisys Inc. stands at -0.0. The total capital return value is set at 0.1. Equity return is now at value -1.90, with -1.02 for asset returns.
Based on Amedisys Inc. (AMED), the company’s capital structure generated 0.28 points at debt to capital in total, while cash flow to debt ratio is standing at 0.25. The debt to equity ratio resting at 0.39. The interest coverage ratio of the stock is 10.79.
Currently, EBITDA for the company is 216.91 million with net debt to EBITDA at 1.68. When we switch over and look at the enterprise to sales, we see a ratio of 1.57. The receivables turnover for the company is 6.27for trailing twelve months and the total asset turnover is 1.08. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.09.
Conclusion
In a nutshell, Amedisys Inc. (AMED) has experienced a better performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
